WG Biotech ApS
- SEC CIK
- 0001753193
No open-market purchases or sales filed in the past year.
Current role at each company
- YMAB Y-mAbs Therapeutics, Inc.Director, 10% Owneras of Sep 18, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists WG Biotech ApS as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 (view filing) | Dec 11 | 1 day | WG Biotech ApSDirector | PPurchase | +6.46K | $6.85 | +$44.2K | +0.1%4.56M after | Duplicate filing |
| Dec 11, 2023 (view filing) | Dec 7 | 4 days | WG Biotech ApSDirector | PPurchase | +6.18K | $6.50 | +$40.2K | +0.1%4.43M after | |
| Dec 11, 2023 (view filing) | Dec 8-11 | 3 days | WG Biotech ApSDirector | PPurchase | +121.4K | $7.01 | +$850.4K | +2.7%4.55M after | 2 lots |
| Dec 1, 2023 (view filing) | Nov 29 | 2 days | WG Biotech ApSDirector | PPurchase | +51.8K | $5.97 | +$309.5K | +1.2%4.43M after | Duplicate filing |
| Nov 29, 2023 (view filing) | Nov 27-28 | 2 days | WG Biotech ApSDirector | PPurchase | +93.2K | $5.60 | +$521.4K | +2.2%4.37M after | 2 lots |
| May 17, 2023 (view filing) | May 15 | 2 days | WG Biotech ApSDirector, Other: See remarks | PPurchase | +101.7K | $9.65 | +$981.8K | +2.4%4.28M after |